STCube Inc
KOSDAQ:052020
STCube Inc
Research & Development
STCube Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
STCube Inc
KOSDAQ:052020
|
Research & Development
-₩7.9B
|
CAGR 3-Years
20%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-33%
|
|
|
M
|
Makus Inc
KOSDAQ:093520
|
Research & Development
-₩614.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
S
|
SAMT Co Ltd
KOSDAQ:031330
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
D
|
Dmoa Co Ltd
KOSDAQ:016670
|
Research & Development
-₩1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-6%
|
|
|
U
|
Unitron Tech Co Ltd
KOSDAQ:142210
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
PC Direct Inc
KOSDAQ:051380
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
STCube Inc
Glance View
STCube, Inc. engages in the development and distribution of information technology (IT) services. The company is headquartered in Seoul, Seoul. The company went IPO on 2001-07-05. Along with subsidiaries, the Company operates its business through two segments. The Information Technology (IT) segment is engaged in the distribution of closed-circuit television (CCTV) lenses and related components. The Biotechnology (BT) segment is engaged in the development and licensing of immunomodulatory anticancer drug therapeutic candidates.
See Also
What is STCube Inc's Research & Development?
Research & Development
-7.9B
KRW
Based on the financial report for Sep 30, 2025, STCube Inc's Research & Development amounts to -7.9B KRW.
What is STCube Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-33%
Over the last year, the Research & Development growth was 48%. The average annual Research & Development growth rates for STCube Inc have been 20% over the past three years , -9% over the past five years , and -33% over the past ten years .
